Internal Medicine, Hematology & Oncology · Tampa, FL
NPI
1689093320
Since 2014
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
12902 Usf Magnolia Dr
Tampa, FL, 33612
Phone (888) 663-3488
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
457 services
Medicare patients, 2024
213
Average age 73
Drug cost, 2024
$3.5M
911 prescriptions
Company payments, 2025
$176
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Juskaran Chadha was code 99214 (office e&m - established), 191 times for 117 patients. In total Juskaran Chadha billed 457 services in 6 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 191 | 117 | $79.84 | $15K |
| 99214 Office E&M - Established | Facility | 165 | 84 | $73.14 | $12K |
| 99205 Office E&M - New | Office | 58 | 58 | $138.87 | $8,054 |
| 99205 Office E&M - New | Facility | 31 | 31 | $128.38 | $3,980 |
By year: 2022 $52K for 570 services; 2023 $43K for 468 services; 2024 $40K for 457 services.
Medicare prescription drug claims, 2024
In 2024, the drug Juskaran Chadha prescribed most often to Medicare patients was Abiraterone Acetate, with 125 prescriptions and refills. In total Juskaran Chadha wrote 911 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Abiraterone Acetate Generic | 125 | 127 | 22 | $304K |
| Prednisone Generic | 124 | 146 | 30 | $428 |
| Orgovyx Relugolix | 81 | 81 | 14 | $217K |
| Bicalutamide Generic | 65 | 108 | 26 | $2,026 |
| Xtandi Enzalutamide | 64 | 64 | 12 | $908K |
| Oxycodone Hcl Generic | 40 | 40 | 21 | $521 |
| Prochlorperazine Maleate Generic | 33 | 33 | 20 | $894 |
| Ondansetron Hcl Generic | 28 | 28 | 24 | $615 |
| Inlyta Axitinib | 27 | 27 | Under 11 | $417K |
| Cabometyx Cabozantinib S-Malate | 21 | 21 | Under 11 | $535K |
| Dexamethasone Generic | 18 | 18 | Under 11 | $79.72 |
| Gabapentin Generic | 18 | 26 | Under 11 | $89.69 |
| Eliquis Apixaban | 16 | 16 | Under 11 | $9,454 |
| Tramadol Hcl Generic | 16 | 16 | Under 11 | $107 |
| Alprazolam Generic | 14 | 14 | Under 11 | $37.64 |
Brand drugs: 278 claims; generic drugs: 633 claims; opioid claims: 78.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Juskaran Chadha $176 ($176 in general payments such as food, travel and fees) from 4 companies. The largest payer was Dendreon Pharmaceuticals LLC with $127.
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 2 | $127 |
| Exelixis Inc. EXEL | 3 | $49.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.